• OPEN AN ACCOUNT
Indian Indices
Sensex
71,924.68 -547.65
( -0.76%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,644.02 91.97
(0.87%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.34903
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
32.11
105289.78
EPS(TTM)
Face Value()
Div & Yield %
40.59
2
1
 

hindustan unilever ltd
Makers Laboratories reports consolidated net profit of Rs 1.09 crore in the March 2026 quarter
May 26,2026
Net profit of Makers Laboratories reported to Rs 1.09 crore in the quarter ended March 2026 as against net loss of Rs 0.05 crore during the previous quarter ended March 2025. Sales rose 5.46% to Rs 35.75 crore in the quarter ended March 2026 as against Rs 33.90 crore during the previous quarter ended March 2025.

For the full year,net profit declined 68.62% to Rs 2.35 crore in the year ended March 2026 as against Rs 7.49 crore during the previous year ended March 2025. Sales rose 16.43% to Rs 140.59 crore in the year ended March 2026 as against Rs 120.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales35.7533.90 5 140.59120.75 16
OPM %14.749.12 -10.486.94 -
PBDT5.873.03 94 15.688.89 76
PBT4.732.13 122 11.154.10 172
NP1.09-0.05 LP 2.357.49 -69